Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gower Publishing

- PMLiVE

Biogen pays Denali $1bn upfront for Parkinson’s disease programme

Deal includes portfolio of small molecule LRRK2 inhibitors

- PMLiVE

Socially distanced strategising

The new normal can improve how you create strategy

Artificial Intelligence in Digital Therapeutics

Leo Grady, CEO of Paige.AI uncovers what it has been like being a pioneer in the digital therapeutic space and the many challenges that come with bringing AI technology to market....

Impetus Digital

Virtual Reality in Medicine and Clinical Research

In the latest episode of Impetus Digital's Fireside Chat, I sit down with Ville Leppälä, Vertical Lead, Research and Medical, at Varjo. We discuss the potential applications of virtual reality, augmented...

Impetus Digital

- PMLiVE

Novartis builds its case for novel MS treatment ofatumumab

Detailed results from phase 3 studies published in NEJM

- PMLiVE

J&J inks $1bn deal with US for coronavirus vaccine

Agreement includes manufacturing and delivery of 100 million doses

- PMLiVE

Pfizer’s Xalkori follow-up Lorbrena hits the mark in first-line lung cancer

ALK inhibitor improved progression-free survival in first-line setting

- PMLiVE

Award-winning agency Porterhouse Medical Group joins imc group with Waterland Private Equity’s support

Porterhouse Medical Group, specialists in medical communications and insights research, is joining imc group with the support of Waterland Private Equity. Porterhouse’s award-winning team will further imc’s ambition to become...

Porterhouse Medical Group

- PMLiVE

AbbVie exits Voyager alliance for Alzheimer’s/Parkinson’s gene therapies

Biotech company did not disclose the reason for the partnership's end

- PMLiVE

Merck enters agreement with Hanmi for investigational NASH drug

Licensing agreement includes $10m upfront payment

- PMLiVE

Virtual Engagement At Porterhouse: Reflections on the past few months

A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world.

Porterhouse Medical Group

- PMLiVE

Novavax reports promising phase 1 results for coronavirus vaccine

Candidate induced immune response in early-stage clinical trial

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links